In rosacea, LL37 activates mTORC1 via Toll-like receptor 2 (TLR2), establishing a mTORC1-LL37-NF-κB positive feedback loop that drives cytokine/chemokine production and sustains inflammation (Deng et al., 2021). The gene discussed is TLR2; the disease is rosacea.